{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:14:29Z","timestamp":1762550069704,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.brachy.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:59:14Z","timestamp":1754434754000},"page":"807-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accessory secondary plaque in brachytherapy for uveal melanoma"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0102-9422","authenticated-orcid":false,"given":"Weilin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6182-7560","authenticated-orcid":false,"given":"Alan W.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara A.","family":"McCannel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.brachy.2025.05.003_bib0001","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hoc.2012.08.004","article-title":"Epidemiology and management of uveal melanoma","volume":"26","author":"Yonekawa","year":"2012","journal-title":"Hematol\/Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.brachy.2025.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","author":"Simpson","year":"2014","journal-title":"Brachytherapy"},{"issue":"12","key":"10.1016\/j.brachy.2025.05.003_bib0003","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.brachy.2025.05.003_bib0004","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bjo.2007.132951","article-title":"Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma","volume":"92","author":"Aaberg","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.brachy.2025.05.003_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0161-6420(01)00902-2","article-title":"Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.brachy.2025.05.003_bib0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.brachy.2025.05.003_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2011.11.011","article-title":"Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.brachy.2025.05.003_bib0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ophtha.2006.06.040","article-title":"Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo","volume":"114","author":"Young","year":"2007","journal-title":"Ophthalmology"},{"issue":"4, Supplement","key":"10.1016\/j.brachy.2025.05.003_bib0009","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.ophtha.2020.01.032","article-title":"The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19","volume":"127","author":"Jampol","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.brachy.2025.05.003_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.brachy.2025.05.003_bib0011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/107327480401100504","article-title":"The Collaborative Ocular Melanoma Study: an overview","volume":"11","author":"Margo","year":"2004","journal-title":"Cancer Control"},{"issue":"9010","key":"10.1016\/j.brachy.2025.05.003_bib0012","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.brachy.2025.05.003_bib0013","article-title":"Staged eye-plaque brachytherapy: a novel approach for large uveal melanoma","volume":"6","author":"Chevli","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2025.05.003_bib0014","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2025.05.003_bib0015","article-title":"Laser treatment for choroidal melanoma: current concepts","author":"Maheshwari","year":"2022","journal-title":"Surv Ophthalmol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:09:06Z","timestamp":1762549746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1538472125000881"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.05.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accessory secondary plaque in brachytherapy for uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}